Separate drug administration led to an increase in GFAP level in VMH: metformin—by 1.51-fold vs. control (p = 0.03) and PA—by 3.13-fold (p < 0.001 vs. control, T2DM, and metformin). The gene discussed is GFAP; the disease is type 2 diabetes mellitus.